SCHEMBL25979896

SCHEMBL25979896

CS(=O)(=O)c1cc(I)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.44
WDR5 P61964 4/20 0.41
RAD51 Q06609 1/20 0.39
PTGS1 P23219 1/20 0.38
CCR2 P41597 1/20 0.37
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ENPP2 Q13822 1/20 0.35
GAA P10253 2/20 0.35
POLB P06746 2/20 0.35
GFER P55789 1/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34
ALPG P10696 1/20 0.34
DNMT1 P26358 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24340091 0.83 CCR2 (0.41) ERN1WDR5RAD51CCR2ALDH1A1
SCHEMBL25979891 0.81 HSD17B10 (0.49) ERN1WDR5RAD51PTGS1ALDH1A1
SCHEMBL3275593 0.78 PTGS1 (0.61) PTGS1ALDH1A1LMNAHPGDHIF1A
SCHEMBL10518952 0.77 SMN1; SMN2 (0.55) PTGS1ALDH1A1LMNAENPP2GAA
SCHEMBL2641943 0.77 TRPA1 (0.50) PTGS1ALDH1A1LMNAHPGDHSD17B10
SCHEMBL18254534 0.77 L3MBTL1 (0.44) RAD51CCR2ALDH1A1LMNAL3MBTL1
SCHEMBL27892677 0.76 RAD51 (0.37) RAD51CCR2ALDH1A1LMNAL3MBTL1
SCHEMBL10960303 0.75 WDR5 (0.56) ERN1WDR5HPGDMCL1
SCHEMBL22396701 0.75 CA3 (0.41) WDR5PTGS1CCR2
SCHEMBL7051361 0.75 L3MBTL1 (0.57) ALDH1A1HPGDHIF1AHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150197-A1 ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2023-08-10 WO disclosed